Related references
Note: Only part of the references are listed.miR-21-mediated decreased neutrophil apoptosis is a determinant of impaired coronary collateral growth in metabolic syndrome
Rebecca Hutcheson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Photoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio
Jingwen Yi et al.
BIOSCIENCE REPORTS (2015)
Applicable advances in the molecular pathology of glioblastoma
Melissa Ranjit et al.
BRAIN TUMOR PATHOLOGY (2015)
Escin reduces cell proliferation and induces apoptosis on glioma and lung adenocarcinoma cell lines
Gulsen Akalin Ciftci et al.
CYTOTECHNOLOGY (2015)
Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide
Khaled Messaoudi et al.
DRUG DISCOVERY TODAY (2015)
Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/-catenin signaling in glioblastoma
FengMing Lan et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Glioblastoma multiforme: Pathogenesis and treatment
Constantinos Alifieris et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Sulforaphane attenuates EGFR signaling in NSCLC cells
Chi-Yuan Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme: A Systematic Review
Li-Juan Yang et al.
CANCER INVESTIGATION (2014)
Interactions among mitochondrial proteins altered in glioblastoma
Ruth F. Deighton et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Molecular targets of isothiocyanates in cancer: Recent advances
Parul Gupta et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Response to imatinib as a function of target kinase expression in recurrent glioblastoma
Marco Ronald Hassler et al.
SPRINGERPLUS (2014)
Sulforaphane Inhibits Growth of Human Breast Cancer Cells and Augments the Therapeutic Index of the Chemotherapeutic Drug, Gemcitabine
Arif Hussain et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Sulforaphane controls TPA-induced MMP-9 expression through the NF-κB signaling pathway, but not AP-1, in MCF-7 breast cancer cells
Young-Rae Lee et al.
BMB REPORTS (2013)
The efficacy of temozolomide for recurrent glioblastoma multiforme
Chao Chen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells
Yujuan Shan et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Review: Molecular mechanism of microglia stimulated glioblastoma invasion
Salvatore J. Coniglio et al.
MATRIX BIOLOGY (2013)
Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme
Manabu Onishi et al.
NEUROLOGIA MEDICO-CHIRURGICA (2013)
Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Poyil Pratheeshkumar et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Effect of Sulforaphane on Growth Inhibition in Human Brain Malignant Glioma GBM 8401 Cells by Means of Mitochondrial- and MEK/ERK-Mediated Apoptosis Pathway
Tzuu-Yuan Huang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
INHIBITION OF RAPAMYCIN-INDUCED AUTOPHAGY CAUSES NECROTIC CELL DEATH ASSOCIATED WITH BAX/BAD MITOCHONDRIAL TRANSLOCATION
S. Carloni et al.
NEUROSCIENCE (2012)
Temozolomide and Other Potential Agents for the Treatment of Glioblastoma Multiforme
Daniel T. Nagasawa et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2012)
PI3Kinase signaling in glioblastoma
M. M. Lino et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Sulforaphane Increases Drug-mediated Cytotoxicity Toward Cancer Stem-like Cells of Pancreas and Prostate
Georgios Kallifatidis et al.
MOLECULAR THERAPY (2011)
Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas
Marc C. Chamberlain
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Multi-targeted prevention of cancer by sulforaphane
John D. Clarke et al.
CANCER LETTERS (2008)
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme - A meta-analysis
Brennan M. R. Spiegel et al.
CNS DRUGS (2007)
The role of matrix metalloproteinases in glioma invasion
M Nakada et al.
FRONTIERS IN BIOSCIENCE (2003)
Share Paper
